Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Prevalence of Parkinson's disease across North America.

Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM; Parkinson’s Foundation P4 Group.

NPJ Parkinsons Dis. 2018 Jul 10;4:21. doi: 10.1038/s41531-018-0058-0. eCollection 2018.

2.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

3.

Parkinson disease with and without Dementia: A prevalence study and future projections.

Savica R, Grossardt BR, Rocca WA, Bower JH.

Mov Disord. 2018 Apr;33(4):537-543. doi: 10.1002/mds.27277. Epub 2018 Jan 22.

PMID:
29356127
4.

Prevalence of and indications for antipsychotic use in Parkinson's disease.

Bower JH, Grossardt BR, Rocca WA, Savica R.

Mov Disord. 2018 Feb;33(2):325-328. doi: 10.1002/mds.27256. Epub 2017 Dec 26.

PMID:
29278275
5.

Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.

Turcano P, Mielke MM, Josephs KA, Bower JH, Parisi JE, Boeve BF, Savica R.

Mov Disord. 2017 Oct;32(10):1439-1446. doi: 10.1002/mds.27125. Epub 2017 Aug 26.

PMID:
28843020
6.

Acute Worsening of Tics on Varenicline.

Mittal SO, Klassen BT, Hassan A, Bower JH, Coon EA.

Clin Neuropharmacol. 2017 Sep/Oct;40(5):231-232. doi: 10.1097/WNF.0000000000000244.

PMID:
28816835
7.

Understanding Parkinson disease in sub Saharan Africa: A call to action for the international neurologic community.

Bower JH.

Parkinsonism Relat Disord. 2017 Aug;41:1-2. doi: 10.1016/j.parkreldis.2017.05.008. Epub 2017 May 11. No abstract available.

PMID:
28528803
8.

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Boeve BF, Graff-Radford J, Rocca WA, Mielke MM.

JAMA Neurol. 2017 Jul 1;74(7):839-846. doi: 10.1001/jamaneurol.2017.0603.

9.

Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Mielke MM, Rocca WA.

Mov Disord. 2017 Feb;32(2):227-234. doi: 10.1002/mds.26839. Epub 2016 Oct 25.

10.

Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients.

Benito-León J, Domingo-Santos A, Hassan A, Ahlskog JE, Matsumoto JY, Bower JH.

Neurology. 2016 Jul 19;87(3):341. doi: 10.1212/WNL.0000000000002907. No abstract available.

PMID:
27432180
11.

Time Trends in the Incidence of Parkinson Disease.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA.

JAMA Neurol. 2016 Aug 1;73(8):981-9. doi: 10.1001/jamaneurol.2016.0947.

12.

Repetitive exercise dystonia: A difficult to treat hazard of runner and non-runner athletes.

Cutsforth-Gregory JK, Ahlskog JE, McKeon A, Burnett MS, Matsumoto JY, Hassan A, Bower JH.

Parkinsonism Relat Disord. 2016 Jun;27:74-80. doi: 10.1016/j.parkreldis.2016.03.013. Epub 2016 Mar 18.

PMID:
27017145
13.

Orthostatic tremor: Clinical, electrophysiologic, and treatment findings in 184 patients.

Hassan A, Ahlskog JE, Matsumoto JY, Milber JM, Bower JH, Wilkinson JR.

Neurology. 2016 Feb 2;86(5):458-64. doi: 10.1212/WNL.0000000000002328. Epub 2016 Jan 8.

PMID:
26747880
14.

Clinical features and autonomic testing predict survival in multiple system atrophy.

Coon EA, Sletten DM, Suarez MD, Mandrekar JN, Ahlskog JE, Bower JH, Matsumoto JY, Silber MH, Benarroch EE, Fealey RD, Sandroni P, Low PA, Singer W.

Brain. 2015 Dec;138(Pt 12):3623-31. doi: 10.1093/brain/awv274. Epub 2015 Sep 13.

15.

Athlete's Dystonia. An Occupational Hazard of Athletes.

Cutsforth-Gregory JK, Bower JH.

Minn Med. 2015 Jul;98(7):42-3. No abstract available.

PMID:
26267919
16.

Addressing neurologic needs in sub-Saharan Africa: An opportunity for multisociety cooperation.

Bower JH, Diop AG, Gouider R, Schmutzhard E.

Neurology. 2014 Sep 23;83(13):1207-9. doi: 10.1212/WNL.0000000000000810. Review. No abstract available.

17.

Multiple system atrophy: prognostic indicators of survival.

Figueroa JJ, Singer W, Parsaik A, Benarroch EE, Ahlskog JE, Fealey RD, Parisi JE, Sandroni P, Mandrekar J, Iodice V, Low PA, Bower JH.

Mov Disord. 2014 Aug;29(9):1151-7. doi: 10.1002/mds.25927. Epub 2014 Jun 7.

18.

Improving the consent process for neuroepidemiologic research in resource-poor settings.

Meta J, Nasuwa F, Mwendo E, Reyburn H, Bower JH.

Neurology. 2014 Mar 11;82(10):895-7. doi: 10.1212/WNL.0000000000000184. No abstract available.

19.

Incidence of dementia with Lewy bodies and Parkinson disease dementia.

Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, Rocca WA.

JAMA Neurol. 2013 Nov;70(11):1396-402. doi: 10.1001/jamaneurol.2013.3579.

20.

Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA.

JAMA Neurol. 2013 Jul;70(7):859-66. doi: 10.1001/jamaneurol.2013.114.

21.

Validity of a screening instrument for neurologic disability in resource-poor African communities.

Bower JH, Mwendo E, Walker R, Maro V, Enquosellasie F, Ali S.

J Neurol Sci. 2012 Sep 15;320(1-2):52-5. doi: 10.1016/j.jns.2012.06.007. Epub 2012 Jul 11.

22.

Risk factors for Parkinson's disease may differ in men and women: an exploratory study.

Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA.

Horm Behav. 2013 Feb;63(2):308-14. doi: 10.1016/j.yhbeh.2012.05.013. Epub 2012 Jun 8.

23.

Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.

Iodice V, Lipp A, Ahlskog JE, Sandroni P, Fealey RD, Parisi JE, Matsumoto JY, Benarroch EE, Kimpinski K, Singer W, Gehrking TL, Gehrking JA, Sletten DM, Schmeichel AM, Bower JH, Gilman S, Figueroa J, Low PA.

J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):453-9. doi: 10.1136/jnnp-2011-301068. Epub 2012 Jan 6.

24.

Clinical failure of botulinum toxin A in movement disorders.

Savica R, Grossardt BR, Bower JH, Klassen BT, Matsumoto JY.

Parkinsonism Relat Disord. 2012 Jan;18(1):73-5. doi: 10.1016/j.parkreldis.2011.07.016. Epub 2011 Aug 30.

PMID:
21880538
25.

Is the answer for Parkinson disease already in the medicine cabinet?: Unfortunately not.

Bower JH, Ritz B.

Neurology. 2011 Mar 8;76(10):854-5. doi: 10.1212/WNL.0b013e31820f2e7a. Epub 2011 Mar 2. No abstract available.

PMID:
21368280
26.

Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.

Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE.

Parkinsonism Relat Disord. 2011 May;17(4):260-4. doi: 10.1016/j.parkreldis.2011.01.009. Epub 2011 Feb 9. Erratum in: Parkinsonism Relat Disord. 2011 Jul;17(6):499.

PMID:
21310646
27.

Dopamine agonists and Othello's syndrome.

Graff-Radford J, Ahlskog JE, Bower JH, Josephs KA.

Parkinsonism Relat Disord. 2010 Dec;16(10):680-2. doi: 10.1016/j.parkreldis.2010.08.007. Epub 2010 Sep 9.

28.

Anxious personality predicts an increased risk of Parkinson's disease.

Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, Therneau TM, Rocca WA.

Mov Disord. 2010 Oct 15;25(13):2105-13. doi: 10.1002/mds.23230.

29.

Novelty seeking and introversion do not predict the long-term risk of Parkinson disease.

Arabia G, Grossardt BR, Colligan RC, Bower JH, Maraganore DM, Ahlskog JE, Geda YE, Rocca WA.

Neurology. 2010 Jul 27;75(4):349-57. doi: 10.1212/WNL.0b013e3181ea15fd.

30.

A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy.

Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, Litvan I, Lang AE, Bower JH, Burn DJ, Low P, Jahanshahi M.

Mov Disord. 2010 Jun 15;25(8):1077-81. doi: 10.1002/mds.22794.

PMID:
20535826
31.

Medical records documentation of constipation preceding Parkinson disease: A case-control study.

Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA.

Neurology. 2009 Nov 24;73(21):1752-8. doi: 10.1212/WNL.0b013e3181c34af5.

32.

Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.

Savica R, Grossardt BR, Carlin JM, Icen M, Bower JH, Ahlskog JE, Maraganore DM, Steensma DP, Rocca WA.

Neurology. 2009 Oct 27;73(17):1381-7. doi: 10.1212/WNL.0b013e3181bd80c1.

33.

Polymyoclonus, laryngospasm, and cerebellar ataxia associated with adenocarcinoma and multiple neural cation channel autoantibodies.

Lim SY, Mason WP, Young NP, Chen R, Bower JH, McKeon A, Pittock SJ, Lang AE.

Arch Neurol. 2009 Oct;66(10):1285-7. doi: 10.1001/archneurol.2009.203.

PMID:
19822786
34.

Bell's palsy preceding Parkinson's disease: a case-control study.

Savica R, Bower JH, Maraganore DM, Grossardt BR, Rocca WA.

Mov Disord. 2009 Jul 30;24(10):1530-3. doi: 10.1002/mds.22616.

PMID:
19526588
35.

Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease.

Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE.

Mayo Clin Proc. 2009 Apr;84(4):310-6. doi: 10.1016/S0025-6196(11)60538-7.

36.

A screening instrument to measure the prevalence of neurological disability in resource-poor settings.

Bower JH, Howlett W, Maro VP, Wangai H, Sirima N, Reyburn H.

Neuroepidemiology. 2009;32(4):313-20. doi: 10.1159/000209265. Epub 2009 Mar 25.

37.

Pessimistic, anxious, and depressive personality traits predict all-cause mortality: the Mayo Clinic cohort study of personality and aging.

Grossardt BR, Bower JH, Geda YE, Colligan RC, Rocca WA.

Psychosom Med. 2009 Jun;71(5):491-500. doi: 10.1097/PSY.0b013e31819e67db. Epub 2009 Mar 25.

38.

Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease.

McKeon A, Ahlskog JE, Bower JH, Josephs KA, Matsumoto JY.

Mov Disord. 2009 Jan 15;24(1):72-6. doi: 10.1002/mds.22301.

PMID:
18831532
39.

Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy.

Rocca WA, Grossardt BR, Geda YE, Gostout BS, Bower JH, Maraganore DM, de Andrade M, Melton LJ 3rd.

Menopause. 2008 Nov-Dec;15(6):1050-9. doi: 10.1097/gme.0b013e318174f155.

PMID:
18724263
40.

The spectrum of disorders presenting as adult-onset focal lower extremity dystonia.

McKeon A, Matsumoto JY, Bower JH, Ahlskog JE.

Parkinsonism Relat Disord. 2008 Dec;14(8):613-9. doi: 10.1016/j.parkreldis.2008.01.012. Epub 2008 Mar 7.

PMID:
18329318
41.

Mapping Africa's way into prominence in the field of neurology.

Owolabi MO, Bower JH, Ogunniyi A.

Arch Neurol. 2007 Dec;64(12):1696-700.

PMID:
18071032
42.

Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease.

Arabia G, Grossardt BR, Geda YE, Carlin JM, Bower JH, Ahlskog JE, Maraganore DM, Rocca WA.

Arch Gen Psychiatry. 2007 Dec;64(12):1385-92.

PMID:
18056546
43.

Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.

Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM.

Arch Neurol. 2007 Oct;64(10):1458-64.

PMID:
17923629
44.

Whole-body tremulousness: isolated generalized polymyoclonus.

McKeon A, Pittock SJ, Glass GA, Josephs KA, Bower JH, Lennon VA, Ahlskog JE.

Arch Neurol. 2007 Sep;64(9):1318-22.

PMID:
17846272
45.

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.

Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd.

Neurology. 2007 Sep 11;69(11):1074-83. Epub 2007 Aug 29.

PMID:
17761551
46.

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, Melton LJ 3rd.

Neurology. 2008 Jan 15;70(3):200-9. Epub 2007 Aug 29.

PMID:
17761549
47.

Neurology training in Africa: the Ethiopian experience.

Zebenigus M, Zenebe G, Bower JH.

Nat Clin Pract Neurol. 2007 Jul;3(7):412-3. Review. No abstract available.

PMID:
17611490
48.

Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease.

Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM.

Mov Disord. 2007 Aug 15;22(11):1607-14.

PMID:
17546668
49.

Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy.

McKeon A, Josephs KA, Klos KJ, Hecksel K, Bower JH, Michael Bostwick J, Eric Ahlskog J.

Parkinsonism Relat Disord. 2007 Dec;13(8):516-9. Epub 2007 Jun 4.

PMID:
17544807
50.

Number of children and risk of Parkinson's disease.

Frigerio R, Breteler MM, de Lau LM, Sanft KR, Bower JH, Ahlskog JE, Grossardt BR; Mariza de Andrade, Maraganore DM, Rocca WA.

Mov Disord. 2007 Apr 15;22(5):632-9.

PMID:
17265462

Supplemental Content

Loading ...
Support Center